3 best performing ASX shares in the week of 15 August 2022
Marc Kennis, August 22, 2022
Best performing ASX shares
The 3 best performing ASX shares in the week of 15 August 2022 were Conico (ASX:CNJ), up 57.1%, PTB Group (ASX:PTB), up 37.3%, and Provaris Energy (ASX:PV1), up 37.1%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Conico (ASX:CNJ)
Industry: Resources
Conico Ltd (ASX:CNJ, formerly Fission Energy Limited) is a mineral exploration company focusing on cobalt, nickel and manganese exploration.
Market Cap: $80m
12 month high / low: $0.001 – $0.10
2. PTB Group (ASX:PTB)
Industry: Industrials
PTB Group Limited (ASX:PTB) is global aviation parts and services supply organisation with operations in turbine engine repair and overhaul, trading in aircraft airframes, turbine engine and related parts, financing as well as lease, rental or hire of aircraft and turbine engines to customers. The company’s management and operations are based in Queensland (Brisbane) and New South Wales.
Market Cap: $199m
12 month high / low: $0.725 – $1.575
3. Provaris Energy (ASX:PV1)
Industry: Chemicals
Provaris Energy Ltd (PV1 , formerly Global Energy Ventures Ltd) is an energy transition company with a mission to deliver compressed shipping solutions for transporting energy to regional markets.
Market Cap: $53m
12 month high / low: $0.038 – $0.165
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Analysts aren’t optimistic about iron ore prices in 2025, will they be right and what will it mean for iron ore stocks?
In which direction will iron ore prices in 2025 go? Chinese trade data would suggest upwards, and indeed prices jumped…
Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025
Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate…
Findi (ASX:FND): Its quadrupled in 12 months off the back of financial services in India
Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…